Member Info for R55DRG

Thanks Dustbin, I apologise for my apparent naivety regarding AIM and will go away and try to learn more about the complexity of this market. Alternatively perhaps I should proceed direct to blatant ramp mode which may be more to your liking.

I assume you are a shorter term holder than myself and others who are invested in SBTX. I would love nothing more than to see this share fly, strangely enough that is why I am invested. One of the reasons I invested in SBTX despite my lack of my apparent understanding of the AIM was the supposedly ‘non binary’ nature of this business. It wasn’t all about Croda you should know, there were also other ‘pillars’, 5 in total which essentially should spread the risk. I’m still hopeful they will bear fruit but we must wait for the numerous cans to stop being kicked before we’ll get the answer to this.

I’m off now to search the interweb to enhance my lack of knowledge.

Toyin - I share your frustration as a long term holder of SBTX. All I hear today is the metallic sound of the can being kicked down the road once again.

The product is out there now but what does that do for SBTX? Croda allegiance is to their customers and shareholders (SBTX management take note). Are they bothered about the ingredient contained within the product and who produces it - hardly as long as they continue to supply it. All they want is a ground breaking product that will replace an ageing (no pun intended) one and to secure sales for the next cycle of their business.

It’s up to SBTX management to capitalise on this but with the NDA still in force it’s going to be difficult. When does the NDA expire or are we going to be gagged forever?

I agree with you Toyin, how can you attract new investors with no information, no forecasts and basically no promotional buzz? I fear SBTX will be left behind in the dust once again because we just don’t have the promotional nouse to exploit our product and a management team who simply cannot communicate in an effective manner. They do however continue to rake in the big bucks and ‘can kicks’ are great for ensuring this continues to be the case.

I’ll finish on past performance - Axisbiotix, it has been four years since the ‘soft’ launch and where are we with another ‘ground breaking ‘ product? Subscribers in the low hundreds not thousands and absolutely no communication to speak of on this product (nor acne) for months.

The shareholders deserve better…..

Friday - 16.37 - 500,000 @ 17.98 - someone needs funds.

‘Never argue with stupid - they will bring you down to their level then beat you with experience’

Samuel Langhorne Clemens

WIILG - excellent post!

We are no doubt still ‘in talks’ with the MNs about Axisbiotix as we are with the US National Psoriasis Association but that’s all we ever seem to be doing. Three years since launch and this should have been flying by now given its undoubted benefits to sufferers.

Nothing more to add, you’ve hit the nail squarely on the head with your post. 👍

Thanks AS - appreciate the clarification. 👍

I have just re read the RNS and but for your clarification would never have guessed that the VIPs had already received the lysate. Very poor communication but pretty much in line with what we expect.

Promises and timescales are becoming a sense of frustration for me but I’m beginning to wonder if I’m expecting too much. The share price as Bel says is static, any RNS is either badly worded or simply insufficient to generate interest.

What happened to acne, but maybe we don’t want to know because if it’s as successful as the Axisbiotix launch, not worth it? Of course there could be an MN out there just formulating a bid to take out both of these products but of course it’s of a sensitive nature and can’t be disclosed.

I’m sure that SA said in the last investor meet that he would be buying shares ‘as soon as’ the closed period’ ended, hasn’t done so but it seems the closed period never ends anyway.

Not worth saying to me sell up if you’re disappointed, as an LTH I’m so much down it’s not worth it, I’ll ride it out because of this. Yes, there is the promise of jam tomorrow but this has been a feature for the last few years but sometime, quickly, this board and company have got to deliver.

We need effective communication, a few director buys wouldn’t go amiss and if someone comes to buy the lot,I’d snap their hand off for 50p a share because some of us aren’t getting any younger.

Just had a reply to my e mail - moderation team are investigating. Hopefully they will sort it out….and quickly!

It’s becoming intolerable - I have filtered and reported but also sent an e mail asking LSE to take action.

Filtered and reported.

I’m sure he stated in the presentation on Monday that there would be no further dilution?

The share price hit over 70p in October 2021 - this was on the much hyped launch of Axisbiotix. Hard to believe it is almost three years since this happened and also to accept that despite many bullish comments and promises that transformation of the business will happen, the only transformation we have seen is that the share price now languishes in single digits.

Little wonder that investors are losing patience with the Executive - we have the usual radio silence despite promises communication would improve.

Each year that goes by without progress, the Executive team receive £600k plus whilst they promise everything and deliver nothing. Each month they string this out means another £50k in their pockets - the gravy train rolls on whilst the true investors suffer.

I see both sides of the ‘argument’ here because both make relevant points. I do think you are correct Bazza, investors are losing faith (myself being one).

Moving the IM in to July is fine with me (what’s another month?) but it simply HAS to deliver something of substance. How many more promises (eg transformed company by Q1) can be made but missed. I appreciate that business doesn’t work to a fixed timescale but we must stop over promising and under delivering its destroying any confidence people have in the Company and Board.

It’s a couple of years since Axis was launched, lots of promises etc but essentially and I may be shouted down for this, it’s a wasted opportunity. How much longer can we continue at this level, the product works, read the reviews, they are excellent. I know, we need to bolt ‘acne’ on to this for an MN to take this and run with it but do we have the luxury of another couple of years, how much longer before our product is irrelevant because some other business markets something similar?

I’ve said in the past I don’t want SBTX to become another OPTI but having read the latter board recently, I’m beginning to think this is a glimpse in to the future of SBTX, so much promise (no pun intended) but never delivered.

Eshaitan - I’m now at the point where there is no option to sell, might as well ride it out. He has promised so much and delivered so little. Some will say have

patience, we’re not at the end of Q1 yet, but we all know the timeline will slip again at that stage.The company will be transformed by then apparently, well he has certainly done that with the share price. At £30k per month remuneration there is no urgency to move things along and forget share bonus milestones, we’re a world away from that. Let’s not forget that he has a very small stake in the company share wise and these were grudgingly purchased a couple of years ago when there was a lot of noise at the time of the placing at 16p. He could of course buy some more now and hopefully lift the price a little but does he have the confidence, at 9p it’s pocket change?

I don’t doubt that the products work but two years plus down the line from the Axis ‘soft’ launch have we lost the market because I’m sure Del Boy could sell more from the local market stall?

I really want this to work because there are undoubtedly benefits to people who actually suffer from the ailments Skin is targeting but how much longer are we going to be told ‘this can’t be discussed because it’s sensitive’ or ‘we have no control over this, it’s a PLC that keeps things close’ or ‘discussions continue with multi nationals’.

I think we have been failed by the management, it’s obvious the market has no confidence in them and I have certainly lost faith.

S it possible that increased Axisbiotix sales have contributed to the apparent reduced cash burn figure?

Just a thought having read a two star Trustpilot review submitted in early August but held pending whilst this was challenged but subsequently posted in late September. This was the only review on Trustpilot submitted by someone called ‘Mateo’ although I have my suspicions this is a pseudonym for someone called ‘The Dictator’ who will be well known to others on this board.

The Axisbiotix team countered with a response which finished with ‘If you read many of our other reviews you will see that the product has worked extremely well for thousands of our customers’. Maybe just an error/overstatement but I would have thought that given the nature of the review, any response from the team would be checked and thoroughly vetted before being posted,

I may be well off the mark here but Stuart did say in the latest interview with Elrico that Axisbiotix retention rates were exceptionally good.

Interesting indeed - depressing certainly. I’m struggling to take one positive from the report. Is there a multi national interested or not - I certainly don’t want to hear in another six months or so that no progress has been made on this front. Croda - should get revenue in 2023, I don’t like the word ‘should’ it doesn’t breed confidence. Beyond that nothing definitive on the other pillars and then a placing at current market price or more realistically given the timing of the release a premium after tomorrows likely rout of the share price.

Belgrano - totally agree, your statement is short and straight to the point. Months since anything official from the company. We know the results already it’s the update that’s important. What company holds back good news? I’m convinced the results and update will be released very late next week just before markets close for the holiday- this in my opinion can only mean one thing.

Aqua - excellent post. I don’t have access to the Q&As so only know what has been commented on following its issue. I like to think this makes me an unbiased observer - the one big ‘take’ I have from your comment is the possibility of results being released after markets close on the 23rd - it’s a ‘red flag’ to me, purely my opinion but if they are good SBTX would be issuing asap not hiding them over the Christmas period. I hope I’m proved wrong.

This purchase went through at 25.25p. Anyone shed any light as to why someone would pay almost 2.5p or 10% above the price of other purchases that went through minutes later? Just interested.

Clio - totally agree. It’s the first time I’ve felt disappointed with Stuart.
The lack of information imparted to shareholders directly is becoming a source of irritation. I don’t think it’s too much to ask for a full, frank and truthful picture of the company and it’s strategy.
The cryptic comments are already being bandied around - suffice to say the garden wall is far too high for me to see if there is any grass whatever colour it is on the other side.
All things aside, we’re invested to grow our ‘hard earned’ and there is precious little at the moment to give confidence.